AbbVie today announced topline results from the Phase 3 EPCORE® DLBCL-1 trial evaluating epcoritamab, a T-cell engaging ...
Scientists have uncovered a new way embryonic cells divide when conventional mechanisms fail. Cell division underpins all ...